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Abstract
The impact of inoculating agar media with positive blood cultures and of performing bacterial identiﬁcation and antimicrobial susceptibil-
ity testing (AST) for positive urine cultures, blood cultures and certain ﬂuid cultures after day hours (night service (NS)) was evaluated
in a clinical microbiology laboratory. The impact of the NS was assessed in terms of decreases in the delays from the time of sampling
to the time at which results became available and of the consequences for patient management and antimicrobial treatment. Two major
beneﬁts were obtained: initiation of earlier appropriate treatment, and change to a reduced-spectrum but still efﬁcient regimen. The
hours of laboratory testing and the availability and transmission of results to the clinical staff were recorded. Concurrently, these hours
were estimated as though laboratory tests had been performed in the absence of NS. Reductions in delay were deﬁned as the differ-
ences between the hours actually spent and the estimated hours. Economic concerns were also considered. Overall, 430 samples for
which an identiﬁcation and/or AST were performed during the NS were included in the study. The NS led to the implementation of
earlier appropriate therapy in 97 cases (22.6%), and to the change to reduced-spectrum but still efﬁcient regimens in 23 additional cases
(5.3%). In conclusion, there appeared to be beneﬁts from a system providing bacterial identiﬁcation and AST overnight, but a study of
the cost-effectiveness of the NS would be useful to back up this observation.
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Introduction
Inappropriate initial antimicrobial therapy has been identiﬁed
as a risk factor for higher mortality rates and for increased
length of hospital stay in the case of bacteraemia [1,2] and
both community-onset and nosocomial pneumonia [3,4]. The
probability of an occurrence of inappropriate initial antimi-
crobial therapy is enhanced by the re-emergence of Gram-
negative healthcare-associated bloodstream infections [5] and
the inﬂux of multidrug-resistant, Gram-negative bacteria into
the hospital setting [6,7], which has been described for several
years. In a study conducted from 1999 to 2007 in a Boston
tertiary-care hospital, a 16-fold increase in bloodstream
infections due to multidrug-resistant Gram-negative bacteria
was observed at hospital admission among elderly patients
[7].
Conversely, appropriate antimicrobial prescribing has been
shown to lead to cost savings [8,9] and is thought to help
prevent the spread of antimicrobial resistance. According to
Kollef [10,11], more rapid microbiological identiﬁcation is
one of the strategies for reducing the frequency of inade-
quate antimicrobial treatment. Several studies performed
during the last decade demonstrated that early reporting of
blood culture results and after-hours clinical liaison had an
impact on the facilitation of timely initiation of appropriate
therapy [12,13] and led to both decreased antibiotic use and
costs [9] and shorter durations of hospitalization [14]. These
reports concerned solely the impact of after-hours Gram
strain examinations and/or inoculations of agar media with
positive blood cultures.
Our objective was to assess the impact of inoculating agar
media with positive blood cultures, and performing bacterial
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identiﬁcations and antimicrobial susceptibility testing (AST)
after day hours in a clinical microbiology laboratory.
Materials and Methods
Study location
The study was performed in a 1600-bed teaching hospital
located in western France. Empirical antibiotic therapy
protocols and a booklet about the practice of antimicrobial
therapy, written by local specialists in infectious diseases and
microbiologists, were widely disseminated in the hospital.
Organization of the 24 h a day service
In our laboratory, a 24-h service has been implemented for
the last 3 years. On weekdays, the day hours are from 08:00
to 17:00. In addition, a laboratory technician works from
13:00 to 21:00, allowing the junction with the night service
(NS).
The NS (from 21:00 to 08:00) is conducted by another
laboratory technician specialized in bacteriology. A staff that
includes three technicians is necessary for the functioning of
the NS. The NS is also operational during weekends. Clinical
microbiologists are responsible for the validation of analysis
results from 08:30 to 18:30 on weekdays and from 09:00 to
14:00 during weekends. Results are transmitted to medical
or nursing staffs and made available in the hospital informa-
tion system only after validation. The NS includes two main
activities. First, Gram stain examination and inoculation are
systematically performed for each specimen sent to the labo-
ratory from clinical wards and for each positive blood cul-
ture identiﬁed during the NS. In addition, urine cultures,
blood cultures and cultures from certain ﬂuids (pleural, artic-
ular or cerebrospinal ﬂuids; ascitis; other ﬂuids collected
perioperatively) previously inoculated on agar media are
monitored two or three times every night. In the case of
colony growth, bacteria are identiﬁed and their susceptibility
to antibiotics is tested.
Microbiological methods
Bacteria were identiﬁed using the Vitek 2 (bioMe´rieux,
Marcy l’Etoile, France) automated identiﬁcation system or
the API system (bioMe´rieux). Depending on the bacterial
species, AST was performed with the Vitek 2 system (in
most cases) or using a disk diffusion test (e.g. in the case of
streptococci or mucoid isolates of Pseudomonas aeruginosa).
Parameters analyzed
The impact of the NS was assessed in terms of decrease in
the delay from the time of sampling to the time at which
results became available, and in terms of the consequences
of this decrease for the management of patient treatment.
We considered the following: the proportion of early results
that led to the implementation of appropriate antimicrobial
therapy (i.e. an inappropriate empirical antimicrobial being
changed to an efﬁcient agent); the change to a reduced-spec-
trum but still efﬁcient regimen; the conﬁrmation that a treat-
ment already prescribed was appropriate; or the
conﬁrmation that an antimicrobial agent was not necessary.
An antibiotic treatment was considered to be appropriate if
at least one effective drug was included in the empirical
treatment.
A subanalysis differentiating samples collected within 48 h
following hospital admission (corresponding to potentially
community-associated infections) and those collected after
this delay (corresponding to potentially nosocomial infec-
tions) was performed.
Data collection
Data were collected prospectively during a 4-month discon-
tinuous period (February 2008 and August–October 2008),
in order to cover different workloads encountered in the
clinical microbiology laboratory over the year. Every week-
day, a clinical microbiologist collected data concerning speci-
mens for which identiﬁcations and AST had been performed
during the preceding NS (including the NS from the preced-
ing weekend on Mondays). For each specimen, data were
collected on a study sheet. They included the names of
patients for whom laboratory tests had been performed,
their hospitalization ward, the hours at which samples had
been initially received in the laboratory, the hours at which
tests had been commenced during the NS, the time at which
results became available in the laboratory, and the hours of
their transmission to medical or nursing staff. Concurrently,
to determine the impact of the NS on the decrease in the
delay from the time of sampling to the time at which results
became available, the hours of the various steps of specimen
analysis were estimated as though they had been performed
in the absence of NS. This estimation was made by consider-
ing two parameters: the laboratory opening hours in the
absence of NS, and the delays in incubation necessary for
culture on agar media (for positive blood cultures), bacterial
identiﬁcation and AST (Fig. 1). The difference between the
measured and the estimated delays was 24 h or 48 h. Data
concerning antimicrobial treatments (antibiotics, dates at
which their administration was begun and discontinued, and
doses administered) were collected prospectively (by the
study of patient records and discussions with clinicians), on
one study sheet, by an intern experienced in public health
and infectious diseases.
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Finally, all data collected were studied by three clinical
microbiologists, who assessed the decrease in the delays and
the consequences for treatments as previously described.
Results
Overall, 430 samples for which a bacterial identiﬁcation and/
or AST were performed during the NS were included in the
study. Urine cultures represented 53.7% (n = 231) of the
overall samples included in the study.
In addition, 143 blood cultures (33.3%) and 56 ﬂuids
(13.0%) were included. The proportion of blood cultures
was 33.3%. Most of the identiﬁcations and antimicrobial sus-
ceptibility tests (68.0%) were performed between 21:00 and
00:00, and 26.7% were performed between 00:00 and 04:00.
The mean delays from the time of sampling to the time at
which identiﬁcation and/or AST were performed were
27.2 ± 9.2 h for urine samples, 33.2 ± 15.5 h for blood cul-
tures, and 40.9 ± 23.7 h for ﬂuid cultures. Missing data were
identiﬁed in two study sheets which were consequently
excluded from the analysis.
In 97 cases (22.7%), the results led to the implementation
of early and appropriate antimicrobial therapy. A preceding
regimen was changed in 49 cases, and an antimicrobial treat-
ment was instituted for 48 patients not treated before.
Escherichia coli represented nearly half of the microorganisms
(Fig. 2). A 24-h beneﬁt was recorded in 83 cases and a 48-h
beneﬁt in 14, so a total of 111 days was recorded for this
major beneﬁt. Blood cultures accounted for 46.8% of those
in days, urine cultures for 43.2%, and ﬂuid cultures for
10.0%. During the study, patients in 30 of the 35 hospital
wards beneﬁted from the initiation of appropriate antimicro-
bial therapy at least 24 h earlier. The four wards mostly con-
cerned were medical wards (i.e. gastroenterology,
haematology, infectious diseases, and cardiology).
In 23 cases (5.4%), the results led to the change to a
reduced-spectrum but still efﬁcient regimen. A 24-h beneﬁt
was recorded in 19 cases, and a 48-h beneﬁt in four (includ-
ing one in which two broad-spectrum antibiotics were
replaced by one with a narrower spectrum). Therefore,
overall, 29 days of broad-spectrum antibiotic use were
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FIG. 1. Initiation of appropriate treatment 48 h earlier for bacteraemia due to extended-spectrum b-lactamase (ESBL)-producing Escherichia coli.
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FIG. 2. Microorganisms (Escherichia coli, Staphylococcus aureus, Pseu-
domonas aeruginosa, Acinetobacter baumannii and Enterococcus faecalis)
involved in the beneﬁt of early appropriate antimicrobial treatment
provided by the night service (n = 97) CNS, coagulase-negative
staphylococci.
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avoided because of the NS. The distribution of the antibiot-
ics avoided because of the NS is presented in Fig. 3. The
ward mainly concerned with this beneﬁt was the infectious
diseases unit (four patients accounting for 5 days).
The comparison of the results for samples analysed within
48 h following hospital admission and those analysed after
this delay showed a higher proportion of results leading to
the implementation of an early antimicrobial therapy for the
latter group (25.0% vs. 20.5%). However, this difference was
not signiﬁcant. There was no difference between the two
groups concerning the implementation of a reduced-spec-
trum but still efﬁcient regimen.
A conﬁrmation that the treatment already prescribed was
appropriate was recorded in 31.6% cases, whereas a conﬁr-
mation that an antimicrobial agent was not necessary was
recorded in 8.6%.
The occurrence of beneﬁts according to the nature of the
bacteriological samples is summarized in Table 1.
For 33.0% of the samples included in the study and for
which the NS provided early transmission of results to medi-
cal or nursing staff, no beneﬁt (according to our parameters)
was identiﬁed. For 70.5% of those cases in which no beneﬁt
was identiﬁed, results were not taken into account by the
wards concerned: absence of treatment administration in
cases of probable infection, or absence of treatment adapta-
tion in cases of inappropriate therapy. It is notable that an
absence of treatment initiation was recorded for 37 patients
with urine cultures showing more than 105 E. coli cells/mL
and more than 105 leukocytes/mL, ﬁve patients with urine
cultures with more than 105 P. aeruginosa cells/mL and more
than 105 leukocytes/mL, and seven patients with blood
cultures and four with cultures of other ﬂuids (articular,
pleural and perioperative) yielding Staphylococcus aureus or
Enterobacteriaceae.
Discussion
To the best of our knowledge, this is the ﬁrst study con-
cerning the evaluation of the usefulness of an NS providing
bacterial identiﬁcation and AST. A laboratory organization
providing such a continuous service with personnel speciﬁ-
cally dedicated to microbiology is resource-consuming and
must therefore be justiﬁed. Most previous reports concern-
ing the impact of after-hours Gram stain examination and/or
inoculation of agar media with positive blood cultures have
demonstrated a beneﬁt for patients and a beneﬁt with
respect to antimicrobial resistance. Similarly, the importance
of the presence of personnel specialized in the ﬁeld of bacte-
riology was conﬁrmed recently by a study reporting the con-
sequences of errors in interpretation of Gram stains from
positive blood cultures [15] and by another study showing
an association between prompt Gram staining of blood cul-
tures and decreased mortality [16].
The main result of our 4-month study was the demonstra-
tion of a 111-day beneﬁt of early appropriate treatment and
a 27-day beneﬁt of reduced-spectrum but still efﬁcient antibi-
otic regimens as a consequence of the NS activity.
Fraser et al. [17] identiﬁed a beneﬁt of appropriate empiri-
cal antibiotic treatment concerning 30-day mortality and
duration of hospital stay. In this study, 30-day mortality rates
were 20.1% and 11.8% in patients who received inappropri-
ate and appropriate treatment, respectively (p < 0.001), and
the mean length of hospital stay was at least 2 days longer
for patients who received inappropriate antibiotic treatment
TABLE 1. Beneﬁts provided by the night service according to the nature of bacteriological samples
Sample N
Early
antibiotic
treatment
N (days)
Early
reduced-spectrum
antimicrobial treatment
N (days)
Conﬁrmation of
appropriate
treatment
N
Conﬁrmation of
the relevance of
the absence of
antibiotic treatment
N
Urine culture 231 48 (48) 2 (2) 74 22
Blood culture 103 39 (51) 16 (20) 44 11
Fluid culture (other) 56 11 (12) 5 (5) 18 4
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FIG. 3. Antimicrobial agents avoided because of the night service.
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(p < 0.002). Concerning urine cultures more speciﬁcally,
some studies demonstrated that inadequate initial antimicro-
bial treatment could lead to longer duration of hospitaliza-
tion. However, this association was mainly noted in non-
E. coli urinary tract infections, in children with urinary or
renal abnormalities, or in children who had received antimi-
crobial therapy in the previous month [18,19]. Similarly, a
study conducted in a tertiary-care hospital and a community
hospital demonstrated a signiﬁcant association between inad-
equate initial antimicrobial treatment and mortality in cases
of infections due to extended-spectrum b-lactamase-produc-
ing Enterobacteriaceae. However, this was true only for non-
urinary infections [20]. A recent study demonstrated an
impact of inappropriate empirical therapy for sepsis due to
methicillin-resistant S. aureus, particularly when high-risk-site
infections (primary bacteraemia, respiratory tract infections,
and intra-abdominal infections) were concerned and when
sepsis occurred in intensive-care units [21]. Concerning
blood cultures, although certain studies demonstrated an
absence of association between inappropriate initial antimi-
crobial treatment and the outcome of patients with bactera-
emia [22–24], others showed that inadequate initial
treatments led to higher risks of mortality, particularly in
patients with certain conditions, such as infections with anti-
biotic-resistant Gram-negative bacilli and bacteraemia with
non-urinary portals of entry (e.g. lung or peritoneum) [1] or
severe neutropenia [25]. A recent study conducted with 904
patients who had microbiologically conﬁrmed severe sepsis
or early septic shock demonstrated that patients receiving
inappropriate initial treatment had a signiﬁcantly higher 28-
day mortality rate than patients who were adequately trea-
ted (39% vs. 24%; p <0.001) [26]. In a study conducted by
Bouza et al. [27] in patients with ventilator-associated pneu-
monia, the determination of MICs with antibiotic strips
placed directly on respiratory tract samples was associated
with fewer days of fever, fewer days of antibiotic administra-
tion until the resolution of the infection, decreased antibiotic
consumption, less Clostridium difﬁcile-associated diarrhoea,
and fewer days of receiving mechanical ventilation in compar-
ison with the use of standard procedures.
Because of the emergence of multiresistant Gram-negative
bacilli [6,7], the probability that broad-spectrum antimicrobial
treatments will be used initially is increasing. Therefore, all
measures that allow narrowing of the spectrum of such treat-
ments as early as possible without compromising patient out-
comes could be relevant in terms of prevention of the
emergence of antimicrobial resistance. In our study, the spec-
trum of the empirical treatment was narrowed for 23 patients.
For ethical reasons, a direct assessment of the situation
without the NS could not be performed. This was one of
the limits of our study. Another limit was the absence of an
evaluation of the impact of Gram stain examination during
the NS. As, during the year 2008, c. 25% of the samples
addressed to the laboratory were received during the NS,
the overall beneﬁt of this part of the NS activity could not
be evaluated. For instance, it would have been relevant to
assess the impact of positive microscopy of urine samples on
early patient discharge with targeted antimicrobial treatment
from the emergency room, or the impact of positive micros-
copy of blood cultures on early targeted antimicrobial treat-
ment. Finally, we did not analyse the impact of the NS on a
potential earlier discharge, particularly for patients with
severe infections such as bacteraemia. Therefore, it was not
possible to perform a relevant evaluation of the cost-effec-
tiveness of the NS, which is an important concern in a per-
iod of resource limitations.
In conclusion, there appeared to be beneﬁts from an NS
providing bacterial identiﬁcation and AST for urine cultures,
blood cultures and ﬂuid cultures, independently of the ori-
gin of the suspected infections (community-acquired or hos-
pital-acquired). However, it would be useful to assess more
precisely the impact of the NS on patients with urinary
tract infections. In addition, the absence of consideration of
the results by clinical wards in one-third of the cases
included in this study underscores the need to conduct
other evaluations, including the relevance of data collections
and the consideration of laboratory results for the prescrip-
tion of antimicrobial agents. Finally, an evaluation of the
compliance with empirical antibiotic therapy protocols
would be useful to reﬁne the interpretation of the results
of this study.
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